Form 4 for PODD Insulet Corporation
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-12 · accession 0001127602-22-027392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-13 | 2022-12-12 | PODD | Spears Michael P | SVP, RA, Compliance | F - Tax | $299.54 | -462 | 11.8K | -4% | -$138.4K |
| DM | 2022-12-13 | 2022-12-12 | PODD | Spears Michael P | SVP, RA, Compliance | M - OptEx | $39.52 | +3,507 | 10.2K | +53% | +$138.6K |
| DM | 2022-12-13 | 2022-12-12 | PODD | Spears Michael P | SVP, RA, Compliance | M - OptEx | $0.00 | -3,507 | 8,646 | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | F | D | 462 | $299.54 | 11,837 | D | — | — | (F1) Constitutes previously owned shares to cover the exercise price of the option being exercised through a stock swap. |
| 2 | Common | Common Stock | 2022-12-12 | M | A | 2,122 | $46.22 | 12,299 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-12 | M | A | 1,385 | $29.26 | 10,177 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2022-12-12 | M | D | 1,385 | $0.00 | 0 | D | $29.26 · — to 2026-02-24 | 1,385 Common Stock | (F2) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-12-12 | M | D | 2,122 | $0.00 | 8,646 | D | $46.22 · — to 2027-02-22 | 2,122 Common Stock | (F2) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |